A case of disseminated
Bladder cancer
Miliary tuberculosis
Mycobacterium bovis BCG
Mycobacterium tuberculosis intravesical BCG
Journal
Respiratory medicine case reports
ISSN: 2213-0071
Titre abrégé: Respir Med Case Rep
Pays: England
ID NLM: 101604463
Informations de publication
Date de publication:
2023
2023
Historique:
received:
19
12
2022
revised:
31
03
2023
accepted:
22
07
2023
medline:
4
8
2023
pubmed:
4
8
2023
entrez:
4
8
2023
Statut:
epublish
Résumé
Bacillus Calmette-Guerin (BCG) intravesical injections are used as adjuvant therapy for superficial bladder cancer. We report a case of a 78-year-old man who developed disseminated
Identifiants
pubmed: 37538979
doi: 10.1016/j.rmcr.2023.101902
pii: S2213-0071(23)00097-7
pmc: PMC10393993
doi:
Types de publication
Case Reports
Langues
eng
Pagination
101902Informations de copyright
© 2023 The Authors. Published by Elsevier Ltd.
Déclaration de conflit d'intérêts
None.
Références
JAMA. 1994 Mar 2;271(9):698-702
pubmed: 8309034
Clin Infect Dis. 2000 Sep;31 Suppl 3:S86-90
pubmed: 11010830
Presse Med. 1993 Oct 2;22(29):1352-6
pubmed: 8248067
J Urol. 2003 Sep;170(3):964-9
pubmed: 12913751
Eur Urol. 2014 Jan;65(1):69-76
pubmed: 23910233
Tuberculosis (Edinb). 2001;81(1-2):71-7
pubmed: 11463226
Tuberculosis (Edinb). 2014 Jan;94(1):15-9
pubmed: 24183617
J Urol. 1992 Mar;147(3):596-600
pubmed: 1538436
Br J Urol. 1995 Feb;75(2):188-92
pubmed: 7850324
J Clin Microbiol. 1997 Mar;35(3):566-9
pubmed: 9041390
Medicine (Baltimore). 2014 Oct;93(17):236-254
pubmed: 25398060
Front Immunol. 2021 Mar 08;12:632478
pubmed: 33763077
J Urol. 1982 Jul;128(1):27-30
pubmed: 6809960
Cancer Control. 2000 Sep-Oct;7(5):476-81
pubmed: 11000618
BJU Int. 2013 Aug;112(3):288-97
pubmed: 23517232
Immunotargets Ther. 2020 Feb 13;9:1-11
pubmed: 32104666